Rentokil Initial (NYSE:RTO) Stock Rating Upgraded by Barclays

Barclays upgraded shares of Rentokil Initial (NYSE:RTOFree Report) to a strong-buy rating in a research note released on Friday morning, Zacks.com reports.

Other research analysts also recently issued reports about the company. Sanford C. Bernstein upgraded Rentokil Initial from an underperform rating to a market perform rating in a report on Monday, July 22nd. UBS Group upgraded Rentokil Initial from a sell rating to a neutral rating in a report on Monday, July 1st. Finally, JPMorgan Chase & Co. assumed coverage on Rentokil Initial in a report on Tuesday, April 23rd. They set a neutral rating for the company. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of Hold and an average target price of $29.00.

Read Our Latest Stock Report on Rentokil Initial

Rentokil Initial Stock Performance

Shares of Rentokil Initial stock opened at $30.38 on Friday. The business has a 50 day moving average price of $29.08 and a 200 day moving average price of $28.20. Rentokil Initial has a 1 year low of $23.39 and a 1 year high of $40.81.

Rentokil Initial Cuts Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Tuesday, September 17th. Investors of record on Friday, August 9th will be given a dividend of $0.2034 per share. The ex-dividend date is Friday, August 9th. This represents a yield of 1.7%.

Institutional Trading of Rentokil Initial

Institutional investors have recently added to or reduced their stakes in the business. Raymond James & Associates boosted its position in Rentokil Initial by 7.5% in the 4th quarter. Raymond James & Associates now owns 283,966 shares of the company’s stock valued at $8,124,000 after buying an additional 19,872 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its position in Rentokil Initial by 959.3% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 174,164 shares of the company’s stock valued at $4,983,000 after buying an additional 157,722 shares during the last quarter. Iridian Asset Management LLC CT boosted its position in Rentokil Initial by 151.0% in the 4th quarter. Iridian Asset Management LLC CT now owns 247,130 shares of the company’s stock valued at $7,070,000 after buying an additional 148,656 shares during the last quarter. NewEdge Wealth LLC boosted its position in Rentokil Initial by 18.0% in the 4th quarter. NewEdge Wealth LLC now owns 13,270 shares of the company’s stock valued at $380,000 after buying an additional 2,027 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its position in Rentokil Initial by 116.0% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 64,400 shares of the company’s stock valued at $1,842,000 after buying an additional 34,588 shares during the last quarter. 9.91% of the stock is owned by hedge funds and other institutional investors.

About Rentokil Initial

(Get Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Featured Articles

Analyst Recommendations for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.